AKTX Akari Therapeutics PLC Total Asset Value of Company
Akari Therapeutics is establishing a comprehensive environment for combating rare pathologies, offering Nomacopan to prevent disability in cases of severe inflammation. The company's technological priority is based on developing treatments for autoimmune disorders by blocking leukotrienes. Total assets at 44.77 are reflected in the price action shown below, confirming a transition to a platform synergy phase following the consolidation of portfolios under a new long-term strategy.
Analytical breakdowns and data insights for company Akari Therapeutics plc (AKTX)
- stock quotes and analyst forecast:
- market capitalization data:
- issuer book value statistics:
- debt burden and liquidity indicators:
All Debt to Shareholders' Equity Ratio Akari Therapeutics|AKTX - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Akari Therapeutics, Plc|AKTX - Company Aggregate Debts|Debts to Book Capitalization Akari Therapeutics, Plc|AKTX - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Akari Therapeutics|Interim Coverage Ratio akaritx.com
- net income and valuation multiples indicators:
Fundamental valuation:Akari Therapeutics
Total assets represent the aggregate volume of company resources, calculated reverse-engineered via ROA to promptly identify liquidity inflows. By analyzing gross asset dynamics, an investor can uncover hidden scaling risks, which is critical for Akari Therapeutics (AKTX), whose pricing power as a monopolist in the orphan drug segment allows for the efficient capitalization of costs through insurance systems.
Key competitors
Total Business Assets ARGX|Aggregate Company Assets BioNTech|Abivax - Total Asset Value of Company|Company Total Assets ADMA|PTGX (Protagonist Corp) - Aggregate Asset Value|Company Total Assets IMVT (Immunovant, Inc.)|Company Total Assets kiniksa.com KNSA|GRFS - Aggregate Company Assets|Aggregate Asset Value ADPT (Adaptive Biotech)|Celldex (CLDX) - Aggregate Company Assets|Cumulative Company Assets Aurinia Corp|BCRX (BioCryst) - Company Total Assets|Company Total Assets veratx.com|Cumulative Company Assets DNTH (Dianthus Therapeutics, Inc.)|PHVS (Pharvaris NV) - Aggregate Asset Value|Company Total Assets ABCL (abcellera.com)|Company Total Asset Base Tourmaline (TRML)|PGEN - Aggregate Company Assets|pharming.com (PHAR) - Cumulative Company Assets|Nektar Therapeutics Inc. (NKTR) - Aggregate Company Assets|Cumulative Company Assets Upstream Bio, Inc.|Cumulative Company Assets ZBIO|Company Total Assets Immunome Bio|Aggregate Company Assets Gossamer Bio, Inc. (GOSS)|kalvista.com - Total Business Assets|Company Total Assets SEPN (Septerna)|Pieris Pharma (PVLA) - Company Assets|Savara Corp - Company Total Assets|RIGL - Company Total Assets|AnaptysBio, Inc. (ANAB) - Aggregate Company Assets|astriatx.com (ATXS) - Company Total Assets|ENGN (enGene) - Company Total Assets|Company Total Assets RAPT Therapeutics Inc.|Aggregate Company Assets Aerovate Therapeutics Inc (JBIO)|ACRS (Aclaris Therapeutics, Inc) - Aggregate Asset Value|Company Total Assets KYTX (Kyverna Therapeutics)|Company Total Asset Base tizianalifesciences.com (TLSA)|CABA: Cumulative Company Assets|Aggregate Asset Value VTYX (Ventyx Biosciences Inc.)|THTX (Theratechnologies Inc) - Cumulative Company Assets|AVTX: Aggregate Business Assets|ELDN (Eledon Pharmaceuticals) - Company Total Assets|AGEN: Aggregate Asset Value|Company Total Assets CLYM|ZURA - Company Assets|Aggregate Company Assets aTyr ATYR|Aggregate Asset Value ADAG|Ikena Oncology, Inc. - Company Total Assets|STTK - Company Total Assets|equilliumbio.com (EQ) - Aggregate Company Assets|Total Asset Value of Company CNTB (Connect Biopharma Holdings Limited)|IMUX (Immunic Therapeutics) - Company Total Assets|Company Assets Atara Biotherapeutics Inc ATRA|Cumulative Company Assets IFRX (InflaRx N.V.)|Company Total Assets x4pharma.com (XFOR)|Adicet Bio, Inc. - Cumulative Company Assets|Aggregate Business Assets CELU (Celularity Inc)|INmune Bio Corp - Company Total Assets|Company Total Asset Base Barinthus Biotherapeutics Corp BRNS|KZR: Company Total Assets|Cumulative Company Assets sabbiotherapeutics.com|Aggregate Company Assets Enlivex Therapeutics Ltd|Q32 Bio Corp (QTTB) - Company Total Asset Base|Company Total Assets GOVX|Company Total Assets Edesa Biotech Corp (EDSA)|Aggregate Company Assets iBio, Inc. IBIO|Company Total Assets Carisma Therapeutics Inc CARM|XTLB: Cumulative Company Assets|Bolt Biotherapeutics - Aggregate Business Assets|HCWB (hcwbiologics.com) - Cumulative Company Assets|Total Business Assets APVO|Aggregate Company Assets AIM ImmunoTech Inc.|Aditxt Corp - Total Asset Value of Company|Company Total Assets GRI|XRTX (XORTX Therapeutics Inc) - Aggregate Asset Value|Company Total Assets HIND (ReShape Lifesciences)|Company Total Assets Revelation Biosciences Corp REVB|INDP - Aggregate Company Assets|Aggregate Asset Value SCNI (scinai.com)|calcimedica.com (CALI) - Aggregate Company Assets|Cumulative Company Assets Affimed N.V.|ALLK (Allakos Inc) - Company Total Assets|Company Total Assets HOOKIPA|Cumulative Company Assets IGMS (IGM Biosciences, Inc.)|ITOS (iteostherapeutics.com) - Aggregate Asset Value|Company Total Assets OCEA (Ocean Biomedical)|Company Total Asset Base TC BioPharm (Holdings) Plc (TCBP)|THRD - Aggregate Company Assets